Drug Profile
Glucagon liquid - Latitude Pharmaceuticals
Alternative Names: Glucagon nanoemulsion - Latitude Pharmaceuticals; Nano-G; Stable liquid glucagon formulation - Latitude PharmaceuticalsLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Latitude Pharmaceuticals
- Class Antihypoglycaemics; Pancreatic hormones
- Mechanism of Action Glucagon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Hypoglycaemia
Most Recent Events
- 03 Apr 2012 Latitude Pharmaceuticals stable glucagon product (Nano-G) is available for licensing as of 03 Apr 2012. http://www.latitudepharma.com/
- 03 Apr 2012 Preclinical trials in Hypoglycaemia in USA (SC)